Legal Decision Could Open the Doors for Truvada Generic Competition One Year Early, Gilead Says

Legal Decision Could Open the Doors for Truvada Generic Competition One Year Early, Gilead Says

Source: 
BioSpace
snippet: 

Gilead Sciences could see its dominance in the HIV market begin to wane as generic competition for Truvada, one of its vaunted therapeutics, hit the market – sooner than initially expected.